• Accueil >
  • Publications >
  • Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

17 nov. 2015Oncotarget

DOI : 10.18632/oncotarget.5149

Auteurs

Steven C. Clifford, Birgitta Lannering, Ed C. Schwalbe, Debbie Hicks, Kieran O' Toole, Sarah Leigh Nicholson, Tobias Goschzik, Anja zur Mühlen, Dominique Figarella-Branger, François Doz, Stefan Rutkowski, Göran Gustafsson, Torsten Pietsch,